Guided Therapeutics (GTHP) Goodwill & Intangibles (2010 - 2011)
Guided Therapeutics (GTHP) reported Goodwill & Intangibles of $409000.0 for Q2 2011, up 36.79% sequentially from $299000.0 in Q4 2010.
Guided Therapeutics (GTHP) Goodwill & Intangibles (2010 - 2011) Analysis & Trends
Guided Therapeutics (GTHP) has 2 years of Goodwill & Intangibles data on file, last reported at $409000.0 in Q2 2011.
- For the quarter ending Q2 2011, Goodwill & Intangibles changed N/A year-over-year to $409000.0; the trailing twelve-month figure through Jun 2011 stood at $409000.0 (changed N/A YoY), and the FY2010 full-year result was $299000.0, changed N/A from the prior year.
- Goodwill & Intangibles grew to $409000.0 in Q2 2011, from $299000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $409000.0 in Q2 2011 to a low of $299000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 409,000.00 |
| Dec 31, 2010 | 299,000.00 |